Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study.

Abstract

Authors

• Khalequ Zaman
  International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh. Electronic address: kzaman@icddrb.org.
• Sheikh Farzana Zaman
  International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh. Electronic address: sfzaman@icddrb.org.
• Farzana Zaman
  International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh. Electronic address: drlisa83@yahoo.co.in.
• Asma Aziz
  International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh. Electronic address: asma.aziz@icddrb.org.
• Sayeed-Bin Faisal
  International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh. Electronic address: sayeed.faisal@icddrb.org.
• Magali Traskine
  GSK, 20 Avenue Fleming, B-1300 Wavre, Belgium. Electronic address: magali.x.traskine@gsk.com.
• Md Ahsan Habib
  GSK, 20 Avenue Fleming, B-1300 Wavre, Belgium. Electronic address: Ahsan.M.Habib@gsk.com.
• Javier Ruiz-Guiñazú
  GSK, 20 Avenue Fleming, B-1300 Wavre, Belgium. Electronic address: javier.x.ruiz@gsk.com.
• Dorota Borys
  GSK, 20 Avenue Fleming, B-1300 Wavre, Belgium. Electronic address: Dorota.D.Borys@gsk.com.

Keywords

External Resources